<DOC>
	<DOCNO>NCT03061435</DOCNO>
	<brief_summary>Almost half woman develop HPV infection lifetime . While infection naturally asymptomatic clear immune system , persist lead development cervical , vulvar , anal lesion eventually cancer . Screening regimens lesion currently place cervix regular Pap test . These Pap test usually involve examination vulva -however , screen procedure exist anal cancer woman . Several study suggest woman exist gynecological lesion likely develop anal lesion anal cancer . Here investigator propose multi-center study seek screen treat anal cancer woman age 40 vulvar lesion stable immune system . The investigator achieve perform anal Pap smear eligible woman conduct High Resolution Anoscopy ( HRA ) appropriate treatment procedure abnormal anal cell . With enough evidence , may indication establish regular anal cancer screen measure potentially underserved population . Hypothesis : The investigator hypothesize least 40 % woman vulvar cancer VIN2/3 abnormal anal cytology . 35 % population hrHPV DNA positive 11 % additionally AIN2/3 . This prospective study may lay groundwork routine anal screening regimen Ontario help shift health policy treat population .</brief_summary>
	<brief_title>Screening Anal Cancer Women With High-grade Vulvar Dysplasia Vulvar Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>Women age â‰¥ 40 Previous diagnosis VIN 2/3 vulvar Women previous diagnosis cancer aside basal cell carcinoma skin , cervical cancer , vulvar cancer Women HIV positive Women currently take immunosuppressant medication Women previous hysterectomy</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vulvar Cancer</keyword>
	<keyword>Cervical Cancer</keyword>
	<keyword>Vulvar Dysplasia</keyword>
	<keyword>Cervical Dysplasia</keyword>
	<keyword>Anal Cancer</keyword>
	<keyword>Anal Dysplasia</keyword>
	<keyword>HPV</keyword>
</DOC>